Evidence map›Paper›PMID 27819235›Full record

ArticleThe Lancet. Oncology2016

Vemurafenib for BRAF

Olivier Huillard, Florence Tenenbaum, Jerome Clerc, Francois Goldwasser, Lionel Groussin

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Lancet. Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Olivier HuillardDepartment of Medical Oncology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, Paris 75014, France. Electronic address: olivier.huillard@aphp.fr.
Florence TenenbaumDepartment of Nuclear Medicine, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, Paris 75014, France.
Jerome ClercDepartment of Nuclear Medicine, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, Paris 75014, France.
Francois GoldwasserDepartment of Medical Oncology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, Paris 75014, France.
Lionel GroussinDepartment of Endocrinology, Cochin Hospital, Assistance Publique Hôpitaux de Paris, Paris Descartes University, Paris 75014, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

IndolesThyroid NeoplasmsHumansProto-Oncogene Proteins B-rafSulfonamidesVemurafenibIndolesProto-Oncogene Proteins B-rafSulfonamidesVemurafenib

Identifiers

PMID27819235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.